Notably, elevated plasma resistin levels have been strongly correlated with systemic inflammation and insulin resistance in rodents and humans, reinforcing the hypothesis that resistin may be a molecular link between obesity and metabolic dysfunction [10]. The gene discussed is RETN; the disease is Insulin resistance.